ADAR1 Capital Management’s Werewolf Therapeutics HOWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.87M Buy
+2,023,331
New +$1.29M 0.09% 150

Other funds holding HOWL

ADAR1 Capital Management's HOWL Position: Q3 2026 in Review

ADAR1 Capital Management opened a new position in Werewolf Therapeutics (HOWL) in Q3 2026: 2,023,331 shares worth $1.87M. The stake represents 0.09% of the portfolio and ranks #150 among its holdings.

38 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.

  • ADAR1 Capital Management held 2,023,331 shares of Werewolf Therapeutics worth $1.87M as of Q3 2026.
  • Werewolf Therapeutics was a new ADAR1 Capital Management position in Q3 2026.
  • Werewolf Therapeutics made up 0.09% of ADAR1 Capital Management's portfolio in Q3 2026, its #150 holding.
  • 38 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.